BioSpace News Archive

BioCapital

AICR Awards Grants to Investigate Links between Lifestyle and Cancer

AICR’s latest grant cycle of awards will fund new research, scheduled to start in 2018.

January 3, 2018
·
3 min read
Mobidiag Release: Novodiag Launch, a New Diagnostic Solution for Infectious Diseases

The new Novodiag solution allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results within a few hours.

January 3, 2018
·
2 min read
Business

GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program

GeoVax’s immuno-oncology program is based on its Modified Vaccinia Ankara Virus-Like Particle platform

January 3, 2018
·
4 min read
Genetown

CRISPR Therapeutics Announces Proposed Public Offering of Common Shares

Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc. are acting as joint book-running managers for the offering.

January 3, 2018
·
3 min read
Onxeo to Attend Key Investor and Partnering Conferences in H1 2018

Onxeo today announced that its management team will attend the following key investor and partnering conferences in the first half of 2018.

January 3, 2018
·
2 min read
SMi Group Release: A Focus on the Areas of the Biggest Growth, Hitting on Key Topics and the Most Recent Studies in the PFS Field

Just 2 weeks remain until SMi opens its doors to host the conference, “Pre-Filled Syringes Europe” set to take place in London on 17 - 18 January.

January 3, 2018
·
1 min read
Business

ASLAN Pharma Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma

The new licensing agreement replaces the prior licensing agreement signed in 2011 to develop and sublicense varlitinib, which did not grant commercial rights to ASLAN.

January 3, 2018
·
4 min read
Genetown

Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA (aflibercept)

The companies plan to initiate a pivotal clinical trial in patients in the first half of 2018.

January 3, 2018
·
6 min read
Business

ResMed to Announce Second Quarter Fiscal Year 2018 Results

The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed’s Investor Relations website at investor.resmed.com.

January 3, 2018
·
2 min read
Policy

Applied BioCode Submits 510(k) Application to FDA for BioCode MDx-3000 with Gastrointestinal Pathogen Panel

The BioCode MDx-3000 system was designed for high volume molecular testing in large hospitals and reference laboratories.

January 3, 2018
·
2 min read